SPARTA, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug supply platform know-how firm targeted on its clinically-validated and patent-protected PLxGuard™ that has the potential to enhance the absorption of many medicine presently on the market and to cut back the danger of abdomen damage related to sure medicine. The Company, with its lead merchandise VAZALORE 81 mg and VAZALORE 325 mg liquid-filled aspirin capsules (referred collectively as “VAZALORE®”), has launched a brand new VAZALORE 325 mg promoting marketing campaign on Facebook that includes legendary skilled baseball pitcher and avid golfer John Smoltz.
“From baseball to golf, I don’t want aches and pains to slow me down,” mentioned Smoltz. “VAZALORE is the only pain reliever I have found that works quickly on my aches and pains and doesn’t upset my stomach.”
“September is Pain Awareness Month, a time dedicated to raising awareness of pain and pain management options, like aspirin. We are very excited to launch our new Facebook campaign with John, a current VAZALORE user and believer in its many benefits,” mentioned Natasha Giordano, President & CEO of PLx Pharma. “Millions of people rely on aspirin for the temporary relief of minor aches and pains. The unique complex inside VAZALORE capsules allows for targeted release of aspirin to temporarily relieve minor aches and pains and is specially designed to help protect the stomach.”
PLx Pharma’s VAZALORE is the primary and solely U.S. Food and Drug Administration (FDA)-approved liquid-filled aspirin capsule. The product was launched in August 2021 and is out there over-the-counter in additional than 30,000 drugstores, supermarkets, mass merchandisers and e-commerce websites nationwide.
About VAZALORE
VAZALORE is an FDA-approved liquid-filled aspirin capsule, obtainable in 81 mg and 325 mg doses. VAZALORE delivers aspirin in another way from plain and enteric coated aspirin merchandise. The particular advanced contained in the capsule is designed for focused launch of aspirin, limiting its direct contact with the abdomen. VAZALORE delivers quick, dependable absorption for ache reduction plus the lifesaving advantages of aspirin. To study extra about VAZALORE®, please go to www.vazalore.com and comply with us on Facebook.
About PLx Pharma Inc.
PLx Pharma Inc. is a commercial-stage drug supply platform know-how firm targeted on enhancing how and the place lively pharmaceutical elements (APIs) are absorbed within the gastrointestinal (GI) tract through its clinically validated and patent protected PLxGuard™ know-how. PLx believes this platform has the potential to enhance the absorption of many medicine presently on the market or in growth, and to cut back the danger of abdomen damage related to sure medicine. To study extra about PLx Pharma Inc. and its pipeline, please go to www.plxpharma.com and comply with us on LinkedIn and Twitter.
CONTACTS:
Janet M. Barth
Vice President, Investor Relations & Corporate Communications, PLx Pharma Inc.
(973) 409-6542
[email protected]
Lisa M. Wilson
Founder & President, In-Site Communications, Inc.
(212) 452-2793
[email protected]
Source: PLx Pharma Inc.
A photograph accompanying this announcement is out there at https://www.globenewswire.com/NewsRoom/AttachmentNg/c1a8bf56-ba0f-47b5-8710-08458436b0e4
